IDEX IDEX BIOMETRICS ASA

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders.

In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares.



Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and CFO, subscribed to 703,883 shares, ISIN NO0013536078, at NOK 3.30 per share.

After the subscription by Pinchcliffe and Anders Storbråten, Mr. Storbråten and close relations hold 7,195,898 or 13,81% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 2.



K-konsult AS, a company closely related to chair Morten Opstad, subscribed to153,343 shares, ISIN NO0013536078, at NOK 3.30 per share, and Morten Opstad, chair, subscribed to 50,000 shares, ISIN NO0013536078, at NOK 3.30 per share.



Contact person

Anders Storbråten, CEO and CFO

Tel:

E-mail:

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit

About this notice

This notice was issued by Kjell-Arne Besseberg, COO, on 23 August 2025 at 13:00 CEST on behalf of IDEX Biometrics ASA. The information about the lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014). The information about shareholding shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA). The information is published in accordance with section 5‑12 of the Norwegian Securities Trading Act.



EN
23/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

IDEX Biometrics launches new product portfolio for payment and access ...

IDEX Biometrics launches new product portfolio for payment and access solutions IDEX Biometrics ASA today announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company’s advanced biometric authentication offerings. This launch marks a key milestone in the company’s strategic transformation and delivery on previously communicated commitments. Link: (idexbiometrics.com) “IDEX is delivering exactly as promised,” said Anders Storbråten, CEO of IDEX Biometrics. "Our new product portfolio positions us at the forefr...

 PRESS RELEASE

Mandatory notice of shareholding 27 August 2025

Mandatory notice of shareholding 27 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 9,40% of the shares and voting rights in IDEX. Sundt AS will hold 2,804,915 shares in IDEX. The ownership will represent 4,93% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section...

 PRESS RELEASE

IDEX Biometrics ASA: First half 2025 report

IDEX Biometrics ASA: First half 2025 report IDEX Biometrics ASA's first half 2025 report is attached to this notice. Recent highlights: Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-yearAt the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024....

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 26 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 2 of the private placement amounted to 4,359,315 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten. The shares – 4,359,315 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,555,213 shares or 20,3 % shares of the tot...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch